🔗 Visit the ClinicalTrials.gov page for NCT00975767
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting the HGF/Met signaling pathway in cancer therapy. | Expert Opin Ther Targets | 2012 | 1.45 |
| 2 | Molecular pathways and therapeutic targets in lung cancer. | Oncotarget | 2014 | 1.16 |
| 3 | AXL kinase as a novel target for cancer therapy. | Oncotarget | 2014 | 1.14 |
| 4 | Targeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor. | Semin Oncol | 2013 | 1.03 |
| 5 | Targeting the HGF-cMET Axis in Hepatocellular Carcinoma. | Int J Hepatol | 2013 | 0.99 |
| 6 | Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer. | Onco Targets Ther | 2013 | 0.85 |
| 7 | MET inhibitors in combination with other therapies in non-small cell lung cancer. | Transl Lung Cancer Res | 2012 | 0.78 |